Antenatal and postnatal cervical precancer screening to increase coverage: experience from Battor, Ghana
- PMID: 38414944
- PMCID: PMC10898892
- DOI: 10.3332/ecancer.2023.1616
Antenatal and postnatal cervical precancer screening to increase coverage: experience from Battor, Ghana
Abstract
Background: Cervical precancer screening in low-resource settings is largely opportunistic with low coverage. Many women in these settings, where the burden of cervical cancer is highest, only visit health institutions when pregnant or after delivery. We explored screening during antenatal and postnatal visits aimed at increasing coverage.
Methods: Pregnant women (in any trimester) attending antenatal care (ANC) and women attending postnatal care (PNC; 6-10 weeks) clinics were screened at Catholic Hospital, Battor and at outreach clinics from February to August 2022 (08/02/2022 to 02/08/2022). At the same visit, cervical specimens were obtained for high-risk human papillomavirus (hr-HPV) DNA testing (with the Sansure MA-6000 PCR platform) followed by either visual inspection with acetic acid (VIA) or mobile colposcopy with the enhanced visual assessment system.
Results: Two hundred and seventy and 107 women were screened in the antenatal and postnatal groups, respectively. The mean ages were 29.4 (SD, 5.4) in the ANC group and 28.6 (SD, 6.4) years in the PNC group. The overall hr-HPV prevalence rate was 25.5% (95% confidence interval (CI), 21.1-29.9) disaggregated as 26.7% (95% CI, 21.4-31.9) in the ANC group and 22.4% (95% CI, 14.5-30.3) in the PNC group (p = 0.3946). Overall, 58.9% of pregnant women (28.3% hr-HPV+) and 66.4% of postnatal women (22.5% hr-HPV+) only visited a health facility when pregnant or after delivery (at Child Welfare Clinics). The VIA 'positivity' rate for all screened women was 5.3% (95% CI, 3.1-7.6), disaggregated into 5.2% (95% CI, 2.5-7.8) in the ANC group and 5.7% (95% CI, 1.3-10.1) in the PNC group (p-value = 0.853).
Conclusion: A significant number of women in Ghana only visit a health facility during pregnancy or after delivery. ANC and PNC clinics would offer opportunities to increase coverage in cervical precancer screening in low-resource settings. Relying on community nurses ensures that such programs are readily integrated into routine care of women and no opportunity is missed.
Keywords: colposcopy; human papillomavirus DNA testing; human papillomavirus infection; postnatal care; prenatal care; uterine cervical neoplasm.
© the authors; licensee ecancermedicalscience.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures




Similar articles
-
HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.Cancer Control. 2024 Jan-Dec;31:10732748241244678. doi: 10.1177/10732748241244678. Cancer Control. 2024. PMID: 38563112 Free PMC article.
-
Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.Ecancermedicalscience. 2023 Dec 8;17:1645. doi: 10.3332/ecancer.2023.1645. eCollection 2023. Ecancermedicalscience. 2023. PMID: 38414966 Free PMC article.
-
A community-focused cervical and breast cancer screening program using a sustainable funding model in a training center in Ghana.BMC Health Serv Res. 2025 Mar 25;25(1):428. doi: 10.1186/s12913-025-12466-6. BMC Health Serv Res. 2025. PMID: 40133922 Free PMC article.
-
Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana.PLOS Glob Public Health. 2023 Apr 20;3(4):e0001830. doi: 10.1371/journal.pgph.0001830. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37079498 Free PMC article.
-
Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.BMC Public Health. 2024 Mar 1;24(1):659. doi: 10.1186/s12889-024-18094-9. BMC Public Health. 2024. PMID: 38429784 Free PMC article.
Cited by
-
Recent Advances in HPV Detection: From Traditional Methods to Nanotechnology and the Application of Quantum Dots.Int J Nanomedicine. 2025 May 21;20:6333-6356. doi: 10.2147/IJN.S524518. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40420910 Free PMC article. Review.
-
Integration and acceptability of cervical cancer screening as part of postnatal care among women attending postnatal clinics in the Accra Metropolis, Greater Accra Region, Ghana.PLOS Glob Public Health. 2024 Dec 31;4(12):e0004070. doi: 10.1371/journal.pgph.0004070. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39739845 Free PMC article.
-
Sociocultural factors influencing women's adherence to colorectal, breast, and cervical cancer screening: a systematic review.BMC Public Health. 2025 Jun 2;25(1):2034. doi: 10.1186/s12889-025-23118-z. BMC Public Health. 2025. PMID: 40457244 Free PMC article.
References
-
- ICO/IARC Information Centre on HPV. Ghana: Human Papillomavirus and Related Cancers, Fact Sheet 2023. 2023. [29/03/23]. [ https://hpvcentre.net/statistics/reports/GHA_FS.pdf]
-
- World Health Organization. WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention. Geneva: World Health Organization; 2021. - PubMed
LinkOut - more resources
Full Text Sources